NMPA Issued the Announcement on Enabling the New Version of Management System for Import Filing of Drugs and Medicinal Materials
Updated: 2019-12-19
To implement the Regulations on Optimizing the Business Environment in China, NMPA and the General Administration of Customs have collaboratively established a management system for import filing of pharmaceuticals and medicinal material imports (hereinafter referred to as the filing system), relying on the One-stop WindowPublic Platform for International Trade. On December 19, 2019, the Announcement on Enabling the New Version of Management System for Import Filing of Drugs andMedicinal Materials was issued to officially launch the filing system on the date of issuance, and the applicants for Inspection shall log in at http://www.singlewindow.cn to submit Drug import filing application.